PBASE-system Safety and Tolerability Clinical Investigation

NCT01798368 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2013-07-02

No results posted yet for this study

Summary

The purpose of this study is to demonstrate that the treatment does not cause any clinically significant effects that would put patients at risk.

Conditions

  • Non-patient Volunteers

Interventions

DEVICE

PBASE system 2.0

Sponsors & Collaborators

  • Chordate Medical

    lead INDUSTRY

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01798368 on ClinicalTrials.gov